Trials / Conditions / B-Cell Non-Hodgkin Lymphoma (NHL)
B-Cell Non-Hodgkin Lymphoma (NHL)
4 registered clinical trials studyying B-Cell Non-Hodgkin Lymphoma (NHL) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CD45BE-HSPC + CART-45 Cells NCT07451054 | University of Pennsylvania | Phase 1 |
| Completed | Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-C NCT02920697 | Institut de Recherches Internationales Servier | Phase 1 |
| Completed | Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL NCT01994382 | Alexion Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Available | A Compassionate Use (CU) Program of Odronextamab NCT05619367 | Regeneron Pharmaceuticals | — |